Uzzan A - Search Results

1

Mesolimbic dopaminergic neurons are not spared by MPTP neurotoxicity in mice.

Melamed E, Rosenthal J, Globus M, Cohen O, Frucht Y, Uzzan A. Melamed E, et al. Among authors: uzzan a. Eur J Pharmacol. 1985 Aug 7;114(1):97-100. doi: 10.1016/0014-2999(85)90528-x. Eur J Pharmacol. 1985. PMID: 3876229

2

Diphenylhydantoin and phenobarbital suppress the dopaminergic neurotoxicity of MPTP in mice.

Melamed E, Martinovits G, Pikarsky E, Rosenthal J, Uzzan A. Melamed E, et al. Among authors: uzzan a. Eur J Pharmacol. 1986 Sep 9;128(3):255-7. doi: 10.1016/0014-2999(86)90773-9. Eur J Pharmacol. 1986. PMID: 3491762

3

Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA.

Melamed E, Rosenthal J, Globus M, Cohen O, Uzzan A. Melamed E, et al. Among authors: uzzan a. Brain Res. 1985 Sep 9;342(2):401-4. doi: 10.1016/0006-8993(85)91146-1. Brain Res. 1985. PMID: 3876139

4

Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP.

Melamed E, Rosenthal J, Cohen O, Globus M, Uzzan A. Melamed E, et al. Among authors: uzzan a. Eur J Pharmacol. 1985 Oct 8;116(1-2):179-81. doi: 10.1016/0014-2999(85)90201-8. Eur J Pharmacol. 1985. PMID: 3876943

5

Amphetamine, but not reserpine, protects mice against dopaminergic neurotoxicity of MPTP.

Melamed E, Rosenthal J, Cohen O, Uzzan A, Globus M. Melamed E, et al. Among authors: uzzan a. Neuropharmacology. 1985 Sep;24(9):923-5. doi: 10.1016/0028-3908(85)90047-4. Neuropharmacology. 1985. PMID: 3877249

6

The neurotoxin MPTP does not affect striatal superoxide dismutase activity in mice.

Pikarsky E, Melamed E, Rosenthal J, Uzzan A, Michowiz SD. Pikarsky E, et al. Among authors: uzzan a. Neurosci Lett. 1987 Dec 4;82(3):327-31. doi: 10.1016/0304-3940(87)90277-1. Neurosci Lett. 1987. PMID: 2827077

7

Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).

Martinovits G, Melamed E, Cohen O, Rosenthal J, Uzzan A. Martinovits G, et al. Among authors: uzzan a. Neurosci Lett. 1986 Aug 29;69(2):192-7. doi: 10.1016/0304-3940(86)90602-6. Neurosci Lett. 1986. PMID: 3489911

8

Effect of serotonergic, corticostriatal and kainic acid lesions on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in mice.

Melamed E, Pikarski E, Goldberg A, Rosenthal J, Uzzan A, Conforti N. Melamed E, et al. Among authors: uzzan a. Brain Res. 1986 Dec 3;399(1):178-80. doi: 10.1016/0006-8993(86)90615-3. Brain Res. 1986. PMID: 3492237

9

In vivo effect of MPTP on monoamine oxidase activity in mouse striatum.

Melamed E, Youdim MB, Rosenthal J, Spanier I, Uzzan A, Globus M. Melamed E, et al. Among authors: uzzan a. Brain Res. 1985 Dec 16;359(1-2):360-3. doi: 10.1016/0006-8993(85)91451-9. Brain Res. 1985. PMID: 3878183

10

Effect of postnatal light deprivation on the ontogenesis of dopamine neurons in rat retina.

Melamed E, Frucht Y, Vidauri J, Uzzan A, Rosenthal J. Melamed E, et al. Among authors: uzzan a. Brain Res. 1986 May;391(2):280-4. doi: 10.1016/0165-3806(86)90293-2. Brain Res. 1986. PMID: 3008950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters